Member Biographical Information
Matthew Lunning, DO
Primary Interest
Dr. Lunning has particular interest in clinical research in rare hematologic malignancies with a focus on early drug development and experimental correlates that leads to enhanced knowledge of how to treat hematologic malignancies.